The biotechnology market size is expected to reach USD 5.80 trillion by 2034, according to a new study by Polaris Market Research. The report “Biotechnology Market Size, Share, Trends & Industry Analysis Report: By Technology, By Application (Bioinformatics, Food & Agriculture, Health, Industrial Processing, Natural Resources & Environment, Others), By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Biotechnology refers to the application of living organisms, cells, or biological systems to produce products and technological innovations that benefit the healthcare, agricultural, industrial, and environmental sectors. Biotechnology involves the integration of biology and various scientific and engineering principles.
The growing prevalence of chronic diseases, along with the introduction of innovative treatments, is driving revenue growth in the biotechnology market. Biotechnology is highly beneficial for treating many diseases, with the pharmaceutical industry utilizing biotechnological techniques ranging from the cultivation of antibiotic-producing microorganisms in fermentation broth to the purification of antibiotic products. Additionally, modern biotechnology has the potential to enhance the effectiveness of various advanced therapeutic approaches specific to particular diseases. It plays a crucial role in the healthcare system, significantly contributing to the production of numerous drugs and vaccines used for treating various conditions. Furthermore, many other medical procedures that are essential to the healthcare system also involve the use of biotechnology.
The DNA sequencing segment accounted for the largest share in 2025 due to an increase in government funding for genetic research. The health segment is expected to experience significant growth due to the increasing burden of diseases worldwide.
The growing demand for organic food highlights the essential role of biotechnology in agriculture, driving revenue growth in the market. Biotechnology offers farmers solutions that make production more efficient. For instance, certain biotech crops can be genetically modified to withstand specific herbicides. This enhances the efficiency and effectiveness of weed control. Additionally, biotechnology supports breeding crops that are resistant to specific plant diseases and insect pests. This allows for the reduction of synthetic pesticide use and improves pest control. These options in crop production not only reduce production costs but also aid countries in meeting the demand for food.
The global key market players are Abbott Laboratories; Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; Johnson & Johnson Services, Inc.; Lonza; Merck KGaA; Novartis AG; Novo Nordisk A/S; Pfizer, Inc., and Sanofi.
There have been important breakthroughs in gene therapy, especially those enabled by CRISPR technology. This has opened new avenues for curing genetic diseases. The Asia Pacific biotechnology market is experiencing significant growth due to increasing investments, enhancements in healthcare infrastructure, and favorable government initiatives. In 2025, the US biotechnology market recorded the largest revenue due to the presence of key players and substantial healthcare expenditure.
Request a free sample copy or read the full market insights : biotechnology market Report